DAWN
Day One Biopharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$21.53
+0.00%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.44x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.02x
- Net debt / EBITDA
- 1.57x
Liquidity & coverage
- Current ratio
- 8.02x
- Quick ratio
- 7.91x
- Cash ratio
- 7.29x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $424.6M
Cash & dividend
- FCF / debt
- -38.52x
- Cash flow / debt
- -37.15x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025